Charles River Labs Intl buy UBS Group AG
Start price
09.11.23
/
50%
€158.95
Target price
09.11.24
€201.48
Performance (%)
26.14%
End price
10.11.24
€200.50
Summary
This prediction ended on 10.11.24 with a price of €200.50. The prediction had a final performance of 26.14%. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Charles River Labs Intl | -13.820% | -13.820% | 0.516% |
| iShares Core DAX® | 1.001% | -1.218% | 13.263% |
| iShares Nasdaq 100 | -1.447% | -4.597% | 0.414% |
| iShares Nikkei 225® | 8.406% | 8.425% | 27.328% |
| iShares S&P 500 | -0.226% | -2.451% | 0.167% |
Comments by UBS_Group_AG for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at UBS Group AG from $250.00 to $215.00. They now have a "buy" rating on the stock.
Ratings data for CRL provided by MarketBeat
In the thread Trading Charles River Labs Intl
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Stopped prediction by UBS_Group_AG for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€195.30
07.11.24
07.11.24
€231.75
07.11.25
07.11.25
-25.40%
08.11.25
08.11.25
Charles River Labs Intl
Start price
Target price
Perf. (%)
€184.90
08.08.24
08.08.24
€220.15
08.08.25
08.08.25
-31.34%
09.08.25
09.08.25
Charles River Labs Intl
Start price
Target price
Perf. (%)
€227.80
15.02.24
15.02.24
€269.47
15.02.25
15.02.25
-36.02%
16.02.25
16.02.25